stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Individuals who meet the diagnostic criteria for stroke and are confirmed by cranial CT or MRI; 2. Those who have experienced their first-ever stroke or have no significant residual sequelae from a previous stroke; 3. Patients with stable vital signs who are capable of cooperating with the required examinations and treatments; 4. Individuals aged between 30 and 75 years; 5. Absence of severe organ diseases or other major illnesses; 6. Patients and their families are informed and consent to participate in this clinical trial. Note: Patients included in this study must fulfill all of the above conditions. Gait Group Inclusion Criteria: 1. Clinically diagnosed with gait abnormalities due to stroke; 2. Capable of walking a short distance of more than 10 meters; 3. Holden Walking Ability Scale classification between level 1 and level 3 (inclusive of both level 1 and level 3). Spasticity Group Inclusion Criteria: 1. Mini-Mental State Examination (MMSE) score > 23 with normal auditory comprehension and expressive abilities; 2. Brunnstrom stage II to IV and upper limb Modified Ashworth Scale classification between 1 and 3. Aphasia Group Inclusion Criteria: 1. Right-handed diagnosed with aphasia using the Chinese version of the Western Aphasia Battery (WAB) (score less than 93.8); 2. Chinese as the first language with an education level of primary school or higher; Able to independently maintain a sitting position for more than 30 minutes and can cooperate to complete language function assessments.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. Individuals with =3 strokes or bilateral cerebral hemisphere lesions; 2. Those with coagulation disorders bleeding risks that prevent cooperation with examinations and acupuncture treatment; 3. Patients with surface damage trauma or infection at acupuncture sites or on the cranial surface; 4. Individuals with severe organ diseases. Gait Group Exclusion Criteria: 1. Those with gait disorders due to non-cerebrovascular diseases or other conditions; 2. Individuals with motor aphasia visual impairments or other factors that hinder treatment cooperation and evaluation; 3. Patients with motor functional impairments such as fractures neuromuscular diseases etc. that affect treatment efficacy. Spasticity Group Exclusion Criteria: 1. Patients with upper limb spasticity due to causes other than stroke; 2. Upper limb spasticity patients who have taken sedatives or muscle relaxants within the last 3 months; 3. Individuals with severe auditory comprehension dysfunction or mental abnormalities; 4. Patients with upper limb bone and joint diseases effusive synovitis etc. causing severe pain that prevents cooperation with examinations and treatment. Aphasia Group Exclusion Criteria: 1. Those with language disorders due to any other degenerative or neurological diseases such as Parkinson's disease intracranial tumors traumatic brain injury etc.; 2. According to safety guidelines individuals with metallic foreign bodies or other electronic devices implanted in the body that are not suitable for rTMS treatment such as those with metallic foreign bodies in the skull cochlear implants or increased intracranial pressure; 3. Patients using drugs that alter cortical excitability (anti-epileptic drugs) sleeping pills benzodiazepines etc; 4. Individuals with a history of mental abnormalities; 5. Patients with a history of epilepsy and a family history of epilepsy; 6. Women who are pregnant or intend to become pregnant and nursing women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The western aphasia battery(WAB);Functional ambulation category scale;Modified Ashworth Scale; | — |
Countries
China
Contacts
First Teaching Hosipital of Tianjin University of Traditional Chinese Medicine